Active Implants Corporation
5865 Ridgeway Center Parkway
Suite 218
Memphis
Tennessee
38120
United States
Tel: 901-762-0352
Fax: 901-767-4205
Website: http://www.activeimplants.com/
Email: info@activeimplants.com
25 articles about Active Implants Corporation
-
World’s First “Artificial Meniscus” Available in Israel
11/18/2019
Active Implants LLC, a company that develops orthopedic implant solutions, announced that two patients in Israel have undergone knee surgery for the company’s NUsurface® Meniscus Implant – the first “artificial meniscus” to be marketed in the Middle East.
-
Final Patient Treated in Clinical Trials for Active Implants’ NUsurface® Meniscus Implant
7/10/2018
176 U.S. Patients Treated with First Artificial Meniscus in SUN and VENUS Trials
-
100th Patient Enrolled In Clinical Trials For Active Implants' Nusurface Meniscus Implant
8/9/2017
-
Active Implants Appoints Charles W. Federico And Gary D. Henley To Board
7/12/2017
-
Active Implants SUN Clinical Trial For Persistent Knee Pain Now Underway In San Diego
6/7/2017
-
Active Implants Locks in First Tranche of a $40 Million Equity Financing
3/16/2017
-
Active Implants Taps Wright Medical Technology Alum as New CEO
2/22/2017
-
Active Implants Corporation Release: Baton Rouge Orthopaedic Clinic Performs First Meniscus Replacement In The South With Nusurface Implant
6/13/2016
-
Active Implants Corporation Release: Salt Lake Regional Medical Center First In The U.S. To Perform Meniscus Replacement To Relieve Persistent Knee Pain In SUN Clinical Trial
5/19/2016
-
Active Implants Corporation Initiates Second Clinical Trial Evaluating NUsurface Meniscus Replacement
2/2/2016
-
Active Implants Corporation Release: VENUS Clinical Trial For Persistent Knee Pain Now Underway In Indiana
11/24/2015
-
Active Implants Corporation Release: VENUS Clinical Trial For Persistent Knee Pain Now Underway In New York City
11/9/2015
-
Active Implants Corporation Release: FDA Has Granted Investigational Device Exemption (IDE) Approval To Conduct A Pivotal Clinical Trial Of The Nusurface® Meniscus Implant For Early Knee Osteoarthritis
5/29/2014
-
Active Implants Corporation Closes $26.0 Million Financing Round
9/3/2013
-
Active Implants Corporation Release: NUsurface® Meniscus Clinical Trial Reaches Key Milestone
1/7/2013
-
Active Implants Corporation Appoints Giltaij as new CEO, Establishes International HQ in The Netherlands
12/5/2012
-
Orthopedic Company Active Implants Corporation Raises $10 Million
1/11/2012
-
Active Implants Corporation Announces Vice President Global Research & Development
4/26/2010
-
Active Implants Corporation Announces CE Class III Medical Device Approval
9/1/2009
-
Active Implants Corporation Names New Chief Financial Officer
6/30/2009